Al-Ola Abdallah, Associate Professor and Plasma Cell Disorder Program Director of the Division of HMCT at the University of Kansas Medical Center, shared a post on LinkedIn:
“ICE-T Congress – Sept 27, Kansas City
Session 2 will spotlight Myeloma and Cellular Therapy Advances:
- Panel 1: Access with CAR-T and Bispecifics
Moderator: Dr. Jeries Kort | Panelists: Drs. Shebli Atrash, Prerna Mewawalla, Forat Lutfi, Jodi Palmer - Panel 2: Side Effects and Management of BCMA and GPRC5D Therapies
Moderator: Dr. Jordan Snyder | Panelists: Drs. Jeries Kort, Prerna Mewawalla, Osama Diab, Bassam Mattar, Jaswinder Singh
Don’t miss these expert-led discussions shaping the future of myeloma care.”
More from Al-Ola Abdallah on OncoDaily.